Back to Search Start Over

Zydusgets US FDA marketing approval for imatinib mesylate tablets

Source :
PharmaBiz. April 9, 2020
Publication Year :
2020

Abstract

Byline: Our Bureau Zydus Cadila has received final approval from the US FDA to market imatinib mesylate tablets, 100 mg and 400 mg. This medication is used to treat certain [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaBiz
Publication Type :
Periodical
Accession number :
edsgcl.619832443